Page last updated: 2024-10-29

indomethacin and Xeroderma Pigmentosum

indomethacin has been researched along with Xeroderma Pigmentosum in 6 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Xeroderma Pigmentosum: A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.

Research Excerpts

ExcerptRelevanceReference
" Treatment with indomethacin, a potent inhibitor of PG biosynthesis, inhibited DMBA-induced inflammation and local immunosuppression."3.71Carcinogen-induced inflammation and immunosuppression are enhanced in xeroderma pigmentosum group A model mice associated with hyperproduction of prostaglandin E2. ( Horio, T; Kuwamoto, K; Miyauchi-Hashimoto, H; Tanaka, K; Urade, Y, 2001)
"Treatment with indomethacin, a potent inhibitor of PG biosynthesis, inhibited UV-induced ear swelling, abrogated local immunosuppression, and decreased the amount of PGE2 in the ear skin of XPA-deficient mice."1.31Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice. ( Eguchi, N; Horio, T; Inui, T; Kuwamoto, K; Miyauchi-Hashimoto, H; Tanaka, K; Urade, Y, 2000)
"Treatment with etretinate and in a later phase with indomethacin and prednisolone was not effective, except for a limited initial response of the tumour to etretinate."1.28Xeroderma pigmentosum: squamous cell carcinoma of the tongue. ( Keukens, F; Kleijer, WJ; Oosterhuis, JW; Panders, AK; van Voorst Vader, PC; Vinks, S, 1989)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tobia, L1
Al-Salem, T1
Ali, ZS1
Qassab, M1
Miller, CS1
Jacob, RJ1
Hiser, DG1
Kuwamoto, K2
Miyauchi-Hashimoto, H2
Tanaka, K2
Eguchi, N1
Inui, T1
Urade, Y2
Horio, T2
Keukens, F1
van Voorst Vader, PC1
Panders, AK1
Vinks, S1
Oosterhuis, JW1
Kleijer, WJ1

Other Studies

6 other studies available for indomethacin and Xeroderma Pigmentosum

ArticleYear
[The therapeutic problem of cutaneous photosensitization. Considerations on a case of xeroderma pigmentosum].
    Archivio per le scienze mediche, 1967, Volume: 123, Issue:3

    Topics: Adolescent; Carcinoma, Basal Cell; Female; Humans; Indomethacin; Photosensitivity Disorders; Skin Ne

1967
Skin cancers in xeroderma pigmentosum: response to indomethacin and steroids.
    Lancet (London, England), 1980, Aug-02, Volume: 2, Issue:8188

    Topics: Adolescent; Adult; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Indomethacin;

1980
UV-enhanced replication of herpes simplex virus in DNA-repair competent and deficient fibroblasts.
    Oral surgery, oral medicine, and oral pathology, 1993, Volume: 75, Issue:5

    Topics: DNA Repair; DNA Replication; DNA, Viral; Fibroblasts; Herpes Simplex; Humans; Indomethacin; Prostagl

1993
Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice.
    The Journal of investigative dermatology, 2000, Volume: 114, Issue:2

    Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cytosol; Dinoprost; Dinoprostone; Disease Models, Anima

2000
Carcinogen-induced inflammation and immunosuppression are enhanced in xeroderma pigmentosum group A model mice associated with hyperproduction of prostaglandin E2.
    Journal of immunology (Baltimore, Md. : 1950), 2001, May-01, Volume: 166, Issue:9

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adjuvants, Immunologic; Administration, Cutaneous; Animals; Anti-I

2001
Xeroderma pigmentosum: squamous cell carcinoma of the tongue.
    Acta dermato-venereologica, 1989, Volume: 69, Issue:6

    Topics: Carcinoma, Squamous Cell; Child; Etretinate; Humans; Indomethacin; Male; Prednisolone; Tongue Neopla

1989